Venn Biosciences Corp — Form D/A
Venn Biosciences Corp of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2019-11-08. The offering totals $8.0M, of which $7.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-11-08
- Form: D/A
- Accession: 0001756172-19-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $7.5M
- Remaining: $500K
- Investors: 10
- Date of first sale: 2018-10-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-323741
Issuer
- Name: Venn Biosciences Corp
- CIK: 0001756172
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2 TOWER PLACE, 5TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 1-888-706-1670
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Adam D'Augelli | Director | Boston, MA |
| Jenny Rooke | Director | Waltham, MA |
| David Michael | Director | Billerica, MA |
| Aldo Carrascoso | Director | SOUTH SAN FRANCISCO, CA |
| Aldo Carrascoso | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Klaus Lindpaintner | Director | South San Francisco, CA |
| Lieza Danan-Leon | Director | San Bruno, CA |
Other filings by this issuer (4)
More